Ignite Creation Date:
2024-05-06 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06247618
Status:
COMPLETED
Last Update Posted:
2024-02-08
First Post:
2023-09-07
Brief Title:
Virtual Reality for Pediatric Palliative Care Team
Sponsor:
Azienda Ospedaliera di Padova
Organization:
Azienda Ospedaliera di Padova
Study Overview
Official Title:
Virtual Reality as a Tool to Promote Healthcare Providers Wellbeing in Pediatric Palliative Care
Status:
COMPLETED
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PPCVR
Brief Summary:
Is virtual reality a useful and usable tool to improve the psychological well-being of PPC operators study primary obtv assessment of occupational psychological well-being divided into stress depression anxiety and risk of burnout in the population of health professionals working in pediatric palliative care verify if the virtual reality tool leads to an improvement change at the level of the investigated items feasibility study The treatment will have a duration of 4 weeks with the execution of two sessions per week with the use of a viewer positioned on the head that allows users to navigate and interact in real time with a three-dimensional 3D environment At time zero T0 the participants will be administered shortly before the application of virtual reality the Mini-Z survey 20 questionnaires the single item burnout question Depression Anxiety Stress Scales 21 DASS-21 and a demographic questionnaire gender age profession shift work years of work in PPCs At the end of the compilation two vision treatments will follow which will take place three to four days apart
At time T1 second week and time T2 third week the DASS-21 will initially be administered followed by two weekly treatments with a visor At the end T3 the compilation of both tests Mini-Z survey 20-the single item burnout question and the DASS-21 will be repeated following the last two applications of the viewer
At time T1 second week and time T2 third week the DASS-21 will initially be administered followed by two weekly treatments with a visor At the end T3 the compilation of both tests Mini-Z survey 20-the single item burnout question and the DASS-21 will be repeated following the last two applications of the viewer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None